Fingerprint
Dive into the research topics of 'EMERGE: A randomized phase II study of the antibody-drug conjugate glembatumumab vedotin in advanced glycoprotein NMB - Expressing breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically